A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer
about
Efficacy and Safety of Aclidinium/Formoterol versus Tiotropium in COPD: Results of an Indirect Treatment ComparisonComparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysisThirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-AnalysisComparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis.Comparing antibiotic treatment for leptospirosis using network meta-analysis: a tutorial.Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis.Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab and Vemurafenib for the Treatment of Patients with Metastatic MelanomaRelative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison.Systematic literature review and network meta-analysis in highly active relapsing-remitting multiple sclerosis and rapidly evolving severe multiple sclerosis.Tolerability of new antiepileptic drugs: a network meta-analysis.Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis.Real-world effectiveness of everolimus-based therapy versus endocrine monotherapy and chemotherapy in patients of HR+/HER2- breast cancer with liver metastasis in the USA.A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer.
P2860
Q26765425-C8E5677F-AD0B-4090-92EF-91486C6C3C46Q26782484-2B6CB2E8-8E9F-41E8-AFC4-0873D4411AF9Q30239022-3FEEF6B1-D82F-4B27-BEFF-2A2F1202AB4AQ36236193-A32117D3-4912-4041-A505-EBE8B09581DCQ36240853-B107EE93-19E0-4C53-98C9-F498D713C658Q36307097-90A5B6BA-5359-4380-9F42-F893E13DFE98Q36840618-0FED4358-9436-4038-9226-DBAA5E9CB530Q37672462-E9EED767-B66C-42B3-9840-8FCE67498D90Q37704322-EC31A83A-3B9E-4463-8592-8511B75BF789Q39220757-8BCB7BEA-97EC-4151-A55D-43EB83661E75Q42374085-87A59879-8F5D-44F4-B18A-2B344619C469Q45289630-2FEB0024-FB97-4159-A995-81FAD1540B51Q50908788-79786491-71A8-4513-8F0E-6B92C39408DA
P2860
A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A process for assessing the fe ...... apy for advanced breast cancer
@ast
A process for assessing the fe ...... apy for advanced breast cancer
@en
type
label
A process for assessing the fe ...... apy for advanced breast cancer
@ast
A process for assessing the fe ...... apy for advanced breast cancer
@en
prefLabel
A process for assessing the fe ...... apy for advanced breast cancer
@ast
A process for assessing the fe ...... apy for advanced breast cancer
@en
P2093
P2860
P356
P1433
P1476
A process for assessing the fe ...... apy for advanced breast cancer
@en
P2093
Brielan Smiechowski
Jeroen P Jansen
Peter Schmid
Shannon Cope
Stephen Saletan
P2860
P2888
P356
10.1186/1741-7015-12-93
P407
P577
2014-06-05T00:00:00Z
P5875
P6179
1036633908